Efforts are under way to educate health care professionals and the public about deep vein thrombosis, a common, potentially fatal disease.
You are here
P&T® Journal contents for February 2005
Letter to the Editor
The authors discuss formulary considerations for the largest therapeutic class of prescription drugs and their efficacy in treating depression and anxiety.
Dr. Prescott reviews the latest developments in treatments for malignant and nonmalignant hematological diseases.
Continuing Education Credit
The authors compare and contrast the safety and efficacy of the newer insulin products—insulin aspart (NovoLog®), lispro (Humalog®), and glargine (Lantus®)—with existing human insulin (e.g., Humulin®, Novolin®).